Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.56 % |
3 Month Return | + 2.58 % |
1 Year Return | + 15.2 % |
Market Stats | |
Previous Close | ₹115.43 |
Open | ₹116.64 |
Volume | 27.30K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹242.87Cr |
P/E Ratio | 11.59 |
PEG Ratio | 9.5 |
Market Cap | ₹242.87 Cr |
P/B Ratio | 1.08 |
EPS | 7.97 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 10.93 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹242.87 Cr | 103.45% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹973.98 Cr | 34.4% | 0.51 | NA | NA | |
NA | ₹586.27 Cr | -3.29% | 0.57 | ₹9 Cr | ₹179 Cr | |
NA | ₹12.94 Cr | 13.85% | 0.69 | NA | NA | |
NA | ₹131.64 Cr | 1.73% | 0.60 | NA | NA |
Organisation | Alpa Laboratories Ltd |
Headquarters | Indore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Alpa Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 3.55 Cr → 7.69 Cr (in ₹), with an average increase of 32.0% per quarter
Retail Holding Up
Retail Investor have increased holdings from 41.96% to 42.35% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 26.6 Cr → 31.85 Cr (in ₹), with an average increase of 16.5% per quarter
Price Rise
In the last 6 months, ALPA stock has moved up by 25.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 57.29% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 151.6% return, outperforming this stock by 118.6%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.2% return, outperforming this stock by 43.9%
FII Holding Down
Foreign Institutions have decreased holdings from 0.74% to 0.35% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 57.29% | 0.00 | |
Foreign Institutions | 0.35% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 42.35% | 0.93 | |
Others | 0% | 0.00 |
Alpa Laboratories Ltd in the last 5 years
Lowest (7.54x)
October 25, 2021
Today (11.59x)
January 30, 2025
Industry (53.04x)
January 30, 2025
Highest (65.88x)
July 22, 2019
Alpa Laboratories Ltd’s net profit jumped 32.82% since last year same period to ₹7.69Cr in the Q2 2024-2025. On a quarterly growth basis, Alpa Laboratories Ltd has generated 50.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Alpa Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Alpa Laboratories Ltd share price today stands at ₹116.64, Open: ₹116.64, Previous Close: ₹115.43, High: ₹119.19, Low: ₹115.63, 52 Week High: ₹144.5, 52 Week Low: ₹69.9.
Alpa Laboratories Ltd is listed on NSE
Alpa Laboratories Ltd is listed on BSE
Today's traded volume of Alpa Laboratories Ltd(ALPA) is 27.30K.
Today's market capitalisation of Alpa Laboratories Ltd(ALPA) is ₹242.87Cr.
Alpa Laboratories Ltd (ALPA) share price is ₹116.64. It is down -19.28% from its 52 Week High price of ₹144.5
Alpa Laboratories Ltd (ALPA) share price is ₹116.64. It is up 66.87% from its 52 Week Low price of ₹69.9
PE Ratio of Alpa Laboratories Ltd is 11.59
PE ratio = Alpa Laboratories Ltd Market price per share / Alpa Laboratories Ltd Earnings per share